Delina Xhafaj

Dr. Delina Xhafaj

Department of Pharmacy, Albanian University, Tirana, Tiranë, Albania
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2016 in Journal of Evaluation in Clinical Practice
Verified
Journal Article
Closed access
PDF file
Klejda HarasaniKlejda Harasani
Klejda Harasani
EBEni Beçi
Eni Beçi
EPElizana Petrela
Elizana Petrela
Delina XhafajDelina Xhafaj
Delina Xhafaj
MGMarta García-Caballos
Marta García-Caballos
ABAurora Bueno-Cavanillas
Aurora Bueno-Cavanillas

17 July 2020 in Pharmacy Practice
Verified
Journal Article
Open access
PDF file
Klejda HarasaniKlejda Harasani
Klejda Harasani
Delina XhafajDelina Xhafaj
Delina Xhafaj
ABAnxhela Begolli
Anxhela Begolli
MPMaría del Carmen Olvera Porcel
María del Carmen Olvera Porcel
Background: Potentially inappropriate prescribing is clearly associated with adverse health consequences among older people. Nevertheless, scarce evidence exists regarding the prevalence of potentially inappropriate prescriptions (PIP) in Albania, a Western Balkans country. Objective: The aim of this study was to assess the prevalence of PIP among older Albanian patients in primary care and to determine the associated sociodemographic and medical factors, including the presence of mild cognitive impairment (MCI). Methods: Cross-sectional study in two primary healthcare centers located in two different cities of Albania, a middle-income country in the Western Balkans. The Montreal Cognitive Assessment (MoCA) tool was applied to evaluate MCI. PIPs were assessed by two trained pharmacists using the Beers criteria 2019 update. Multivariate logistic regression analysis was conducted for possible risk factors predicting PIP in the study population. Results: At least one PIP was identified among 40.23 % of the participants (174 older patients) and 10.35 % had more than one PIP. MCI was detected among 79.31 % of the patients. The most commonly represented drug groups in PIP were diuretics (24.71 %), benzodiazepines in the presence of MCI and antidepressants (both 8.62 %). The lack of electrolytes monitoring was the most common reason for PIP. According to the multivariate analysis, the only statistically significant association observed was between PIP and number of drugs prescribed [three to four drugs (OR 3.34; 95% CI 1.65:6.76), five or more than five drugs (OR 4.08; 95% CI 1.42:11.69)]. Conclusions: About four out of 10 older Albanian patients experience PIP in primary care. Further studies are needed for a comprehensive estimation of the prevalence and factors associated with PIP, particularly among elderly with mild cognitive impairment.

8 February 2021 in International Journal of Pharmacy Practice
Verified
Journal Article
Open access
PDF file
Klejda HarasaniKlejda Harasani
Klejda Harasani
Delina XhafajDelina Xhafaj
Delina Xhafaj
ALAdrisa Lekaj
Adrisa Lekaj
LVLivia Veshi
Livia Veshi
MPMaría del Carmen Olvera Porcel
María del Carmen Olvera Porcel
Objectives: To assess the prevalence of mild cognitive impairment (MCI) and its correlated factors among elderly Albanian patients using different screening tools applied by clinical pharmacists. Methods: Patients aged 60 years old or more from two primary care centers located in two Albanian cities were included in the study. Two clinical pharmacists applied the MoCA/MoCA B (Montreal Cognitive Assessment/Basic) and the Mini-Cog in Albanian. A predictive multivariate logistic regression analysis and Kappa statistic were conducted. Key findings: The prevalence of MCI using MoCA/MoCA B and Mini-Cog scales was 75.73 and 20.39%, respectively. There was a poor degree of agreement between them (Kappa 2.38). Older men had an increased risk of MCI. Conclusions: The involvement of clinical pharmacists in screening for MCI might help in selecting vulnerable individuals for more specialized examination. The MoCA/MoCA B tool is recommended for higher sensitivity.

7 November 2024 in Pharmacy
Verified
Journal Article
Open access
PDF file
Delina XhafajDelina Xhafaj
Delina Xhafaj
SVSonila Vito
Sonila Vito
AXAlban Xhafaj
Alban Xhafaj
Drug shortages are a significant global issue, particularly affecting healthcare systems in resource-limited countries such as Albania. Pharmacists play a critical role in managing these shortages, yet little is known about their experiences and perspectives. This study aims to explore pharmacists’ views on the current drug shortages in Albania, identifying the most affected drug classes, and suggesting potential strategies for mitigating these shortages. A cross-sectional survey was conducted with 93 pharmacists across Albania between December 2023 and May 2024. Data were collected using an online questionnaire that addressed the types of drugs experiencing shortages, the causes of these shortages, and pharmacists’ coping strategies. Cardiovascular and central nervous system medications were reported as the most frequently affected, with supply chain disruptions, regulatory hurdles, and low domestic production cited as key contributors. The findings suggest an urgent need for national policy reforms focusing on improving supply chain resilience and boosting the local pharmaceutical production. The pharmacists proposed mitigation strategies, including stricter regulatory oversight, improved communication channels, and increased local production to reduce dependence on imports. These recommendations underscore the study’s contribution to understanding how tailored, pharmacist-informed strategies could strengthen Albania’s healthcare system.

26 November 2025 in E3S Web of Conferences
Verified
Conference Paper
Open access
PDF file
RSRenta Sanxhaku
Renta Sanxhaku
Delina XhafajDelina Xhafaj
Delina Xhafaj
DDDitila Doracaj
Ditila Doracaj
EGEdi Grabocka
Edi Grabocka
Homocysteine, a sulfur-containing amino acid, has been increasingly linked to metabolic disturbances, particularly insulin resistance and type 2 diabetes mellitus (T2DM). This review explores the relationship between elevated homocysteine levels and impaired insulin sensitivity by synthesizing evidence from epidemiological, mechanistic, and genetic studies. A structured literature search was conducted using PubMed, Scopus, and Google Scholar, following PRISMA guidelines and guided by the PICOT model. Studies published over the past two decades were screened, and 32 met the inclusion criteria after full-text review. Findings indicate a consistent association between hyperhomocysteinemia and insulin resistance, with proposed mechanisms including oxidative stress, endothelial dysfunction, mitochondrial impairment, and direct inhibition of insulin signaling pathways. Mendelian randomization studies further suggest a potential causal relationship. However, intervention trials using vitamin B supplementation have shown mixed results, and weight loss alone does not appear to lower homocysteine levels. Despite its promising role as a biomarker, the clinical relevance of homocysteine in predicting or treating insulin resistance remains uncertain. Further research is needed to determine its utility in risk stratification and therapeutic intervention. Further research is required to determine its utility in risk stratification and therapeutic intervention, and to support the development of health policy guidelines for its application in real practice.